Sen. Rand Paul. Photo: Win McNamee/Getty Images

The Trump administration is urging commercial labs to prioritize testing inpatients for the novel coronavirus, Vice President Mike Pence said Sunday, a reflection of how we're prioritizing America's woefully inadequate supply of diagnostic tests.

Why it matters: A high-profile example of the pitfalls of this strategy — which essentially means that only the sickest patients get tested — is Sen. Rand Paul's positive diagnosis. Paul is asymptomatic, but recently was in close contact with other senators, leading them to self-quarantine.

  • That's how this is supposed to work; it cuts off the virus's line of transmission by keeping everyone who has been exposed quarantined at home. But it's impossible to do this across the population when we don't know who is infected.
  • Our next-best option is for everyone to stay home and assume that they have the virus. But plenty of people have been ignoring social distancing guidance.

The big picture: As researchers learn more about the virus, it's becoming more apparent that asymptomatic carriers are likely important to its spread.

The latest: Our testing issues are no longer about a lack of labs making them. The latest problem is that even as our testing capability ramps up, we face shortages of the supplies used to make and conduct the tests.

  • There are also concerns that people seeking tests who aren't severely ill will waste resources beyond the tests themselves, like personal protective equipment, and expose non-infected people.

What they're saying: "We are in a new phase of this fight. Only one thing matters now: treatment of the gravely ill," tweeted Mark Levin, chair of New York City Council health committee.

Go deeper ... Report: Data suggests 33% of coronavirus cases in China were asymptomatic

Go deeper

14 mins ago - Health

U.S., Canada and U.K. accuse Russia of trying to steal coronavirus vaccine research

Russian President Vladimir Putin. Photo: Alexei Druzhinin\TASS via Getty Images

Hackers associated with Russian intelligence services are trying to steal information from researchers involved in coronavirus vaccine development, according to a joint advisory by U.K., U.S. and Canadian authorities published Thursday.

The big picture: This isn't the first time a foreign adversary has been accused of attempting to steal COVID-19-related research. U.S. officials in May announced an uptick in Chinese-government affiliated hackers targeting medical research and other facilities in the U.S. for data on a potential cure or effective treatments to combat the virus.

M&A activity falls despite early coronavirus fears

Illustration: Aïda Amer/Axios

In April, several prominent Democrats proposed a moratorium on large mergers and acquisitions. Their argument was that the pandemic would embolden the strong to pounce on the weak, thus reducing competition.

Fast forward: The moratorium never materialized. Nor did the M&A feeding frenzy.

More than 32 million Americans are receiving unemployment benefits

Photo: Jay L. Clendenin / Los Angeles Times via Getty Images

More than 32 million Americans are receiving some form of unemployment benefits, according to data released by the Labor Department on Thursday.

Why it matters: Tens of millions of jobless Americans will soon have a smaller cash cushion — as coronavirus cases surge and certain parts of the country re-enter pandemic lockdowns — barring an extension of the more generous unemployment benefits that are set to expire at the end of the month.